Need help finding what you are looking for?
Contact Us
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933339
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933339
Safety Lancets Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Growth Factors of safety lancets Market
The global safety lancets market was valued at USD 1.21 billion in 2025 and is projected to grow to USD 1.34 billion in 2026, reaching USD 3.28 billion by 2034, registering a robust CAGR of 11.81% during the forecast period. Safety lancets are specialized medical devices designed for blood sampling, primarily used for diabetes management and other diagnostic applications. These devices incorporate safety features to minimize accidental needle-stick injuries, enhancing protection for both healthcare providers and patients.
The growing prevalence of diabetes and other chronic diseases, along with technological innovations and regulatory pressures promoting safer medical practices, are key factors driving market growth. North America led the market in 2025, accounting for 37.74% of the global share, due to the high incidence of diabetes and significant reimbursement programs for blood glucose monitoring products.
Market Dynamics
Drivers: The increasing incidence of diabetes is a major driver of the safety lancets market. According to the Institute for Health Metrics and Evaluation (2023), over half a billion individuals globally are living with diabetes. The rising preference for home monitoring solutions, convenience, and less invasive blood sampling methods further propel demand. Patients increasingly seek comfort and compliance in regular testing routines, making safety lancets essential tools for effective disease management.
Restraints: High cost remains a challenge, especially in developing regions. Safety lancets typically cost USD 4.87-5.06 per 100 lancets, compared to USD 2.37-4.22 for traditional lancets, limiting adoption among price-sensitive healthcare providers and patients.
Opportunities: The growing trend of home healthcare monitoring presents significant opportunities. Self-monitoring of blood glucose (SMBG) is increasing globally; a 2023 study in the Indian Journal of Medical Specialties reported that 35% of patients used glucometers for SMBG at home. Safety lancets are well-suited for home use due to ease of use and reduced risk of needle-stick injuries.
Challenges: Limited healthcare spending in developing countries restricts market growth. Low public healthcare budgets, such as Bangladesh's 2.34% GDP expenditure on healthcare, hinder the availability and adoption of advanced devices.
Market Trends
A key trend is the shift toward automatic/pressure-activated safety lancets, favored for their automatic needle retraction and reduced risk of injury. Studies indicate that automatic lancets cause less pain and improve efficiency in both clinical and home care settings.
Segmentation Analysis
By Type:
- Button-activated lancets dominate, holding 62.57% market share in 2026, due to ease of use and simple activation mechanisms.
- Pressure/contact-activated lancets offer consistent puncture depth and enhanced safety, with increasing adoption in developed regions.
By Incision Type:
- Needle lancets dominate due to safety features and reduced pain.
- Blade lancets are growing, especially for neonatal screening and dried blood spot tests, providing higher blood volumes for certain diagnostics.
By Age Group:
- Adults dominate due to frequent blood glucose, HbA1c, and cholesterol testing.
- Pediatrics are witnessing growth due to type 1 diabetes monitoring and SMBG recommendations.
By Application:
- Blood glucose monitoring leads with 59.67% market share in 2026, driven by diabetes prevalence.
- Hemoglobin testing is projected for the fastest growth, while cholesterol testing shows moderate adoption.
- Other applications include lipid profiling, coagulation monitoring, and dried blood spot tests.
By End-user:
- Hospitals & clinics lead with 41.40% market share in 2026 due to patient visits and assisted monitoring programs.
- Home care is expected to achieve the highest CAGR due to SMBG adoption.
- Others include blood banks, diagnostic labs, academic institutions, and nursing homes.
Regional Outlook
- North America: Market value of USD 0.46 billion in 2025, reaching USD 0.51 billion in 2026, driven by high diabetes prevalence and strong reimbursement policies.
- Europe: Key markets include the U.K. (USD 0.03 billion in 2026) and Germany (USD 0.10 billion in 2026) due to advanced healthcare infrastructure.
- Asia Pacific: Projected highest CAGR with Japan (USD 0.04 billion), China (USD 0.15 billion), and India (USD 0.08 billion) in 2026, supported by domestic manufacturers and large diabetic populations.
- Latin America: Growth due to rising healthcare expenditure and home monitoring demand.
- Middle East & Africa: Steady growth attributed to diabetes awareness and favorable policies.
Competitive Landscape
The market is highly fragmented, with major players such as BD, HTL-STREFA, Abbott, Cardinal Health, B. Braun SE, Terumo Medical Corporation, SARSTEDT AG & Co. KG, and YPSOMED focusing on product innovation, geographic expansion, and distribution partnerships. Key industry developments include product launches, national agreements, and participation in global medical exhibitions.
Conclusion
The global safety lancets market is poised for substantial growth, from USD 1.21 billion in 2025 to USD 3.28 billion by 2034, driven by rising diabetes prevalence, home monitoring adoption, and technological advancements in lancet safety. North America remains the dominant market, while Asia Pacific offers the highest growth potential. Although high costs and limited healthcare spending in some regions present challenges, the increasing focus on patient safety and convenient monitoring solutions positions the market for sustained expansion. Key players with strong R&D and distribution networks are expected to consolidate their leadership, shaping the competitive landscape in the coming years.
Segmentation By Type
- Button-activated
- Pressure/Contact-activated
By Incision Type
- Needle
- Blade
By Age Group
- Adult
- Pediatric
By Application
- Blood Glucose Monitoring
- Hemoglobin Testing
- Cholesterol Testing
- Others
By End-user
- Hospitals & Clinics
- Home Care
- Others
By Region
- North America (By Type, Incision Type, Age Group, Application, End-user, and Country)
- U.S.
- Canada
- Europe (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
- Germany
- U.K.
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, By Incision Type, Age Group, Application, End-user, and Country/Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Product Code: FBI113261
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries/Region, 2025
- 4.2. Number of SMBG User, By Key Countries/Region, 2025
- 4.3. Advancements in Safety Lancets
- 4.4. Overview: Reimbursement Scenario
- 4.5. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
5. Global Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Button-activated
- 5.1.2. Pressure/Contact-activated
- 5.2. Market Analysis, Insights and Forecast - By Incision Type
- 5.2.1. Needle
- 5.2.2. Blade
- 5.3. Market Analysis, Insights and Forecast - By Age Group
- 5.3.1. Adult
- 5.3.2. Pediatric
- 5.4. Market Analysis, Insights and Forecast - By Application
- 5.4.1. Blood Glucose Monitoring
- 5.4.2. Hemoglobin Testing
- 5.4.3. Cholesterol Testing
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By End-user
- 5.5.1. Hospitals & Clinics
- 5.5.2. Home Care
- 5.5.3. Others
- 5.6. Market Analysis, Insights and Forecast - By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
6. North America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Button-activated
- 6.1.2. Pressure/Contact-activated
- 6.2. Market Analysis, Insights and Forecast - By Incision Type
- 6.2.1. Needle
- 6.2.2. Blade
- 6.3. Market Analysis, Insights and Forecast - By Age Group
- 6.3.1. Adult
- 6.3.2. Pediatric
- 6.4. Market Analysis, Insights and Forecast - By Application
- 6.4.1. Blood Glucose Monitoring
- 6.4.2. Hemoglobin Testing
- 6.4.3. Cholesterol Testing
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By End-user
- 6.5.1. Hospitals & Clinics
- 6.5.2. Home Care
- 6.5.3. Others
- 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Button-activated
- 7.1.2. Pressure/Contact-activated
- 7.2. Market Analysis, Insights and Forecast - By Incision Type
- 7.2.1. Needle
- 7.2.2. Blade
- 7.3. Market Analysis, Insights and Forecast - By Age Group
- 7.3.1. Adult
- 7.3.2. Pediatric
- 7.4. Market Analysis, Insights and Forecast - By Application
- 7.4.1. Blood Glucose Monitoring
- 7.4.2. Hemoglobin Testing
- 7.4.3. Cholesterol Testing
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By End-user
- 7.5.1. Hospitals & Clinics
- 7.5.2. Home Care
- 7.5.3. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.6.1. Germany
- 7.6.2. U.K.
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
8. Asia pacific Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Button-activated
- 8.1.2. Pressure/Contact-activated
- 8.2. Market Analysis, Insights and Forecast - By Incision Type
- 8.2.1. Needle
- 8.2.2. Blade
- 8.3. Market Analysis, Insights and Forecast - By Age Group
- 8.3.1. Adult
- 8.3.2. Pediatric
- 8.4. Market Analysis, Insights and Forecast - By Application
- 8.4.1. Blood Glucose Monitoring
- 8.4.2. Hemoglobin Testing
- 8.4.3. Cholesterol Testing
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By End-user
- 8.5.1. Hospitals & Clinics
- 8.5.2. Home Care
- 8.5.3. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Button-activated
- 9.1.2. Pressure/Contact-activated
- 9.2. Market Analysis, Insights and Forecast - By Incision Type
- 9.2.1. Needle
- 9.2.2. Blade
- 9.3. Market Analysis, Insights and Forecast - By Age Group
- 9.3.1. Adult
- 9.3.2. Pediatric
- 9.4. Market Analysis, Insights and Forecast - By Application
- 9.4.1. Blood Glucose Monitoring
- 9.4.2. Hemoglobin Testing
- 9.4.3. Cholesterol Testing
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By End-user
- 9.5.1. Hospitals & Clinics
- 9.5.2. Home Care
- 9.5.3. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
10. Middle East & Africa Safety Lancets Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Button-activated
- 10.1.2. Pressure/Contact-activated
- 10.2. Market Analysis, Insights and Forecast - By Incision Type
- 10.2.1. Needle
- 10.2.2. Blade
- 10.3. Market Analysis, Insights and Forecast - By Age Group
- 10.3.1. Adult
- 10.3.2. Pediatric
- 10.4. Market Analysis, Insights and Forecast - By Application
- 10.4.1. Blood Glucose Monitoring
- 10.4.2. Hemoglobin Testing
- 10.4.3. Cholesterol Testing
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By End-user
- 10.5.1. Hospitals & Clinics
- 10.5.2. Home Care
- 10.5.3. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.6.1. GCC
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. BD
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. SARSTEDT AG & Co. KG
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Greiner Bio-One International GmbH
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. HTL-STREFA (MTD Medical Technology and Devices)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Terumo Medical Corporation
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. B. Braun SE
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Abbott
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Cardinal Health
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. YPSOMED
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Biosense Technologies Private Limited
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.1. BD
Product Code: FBI113261
List of Tables
- Table 1:Global Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 2:Global Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 3:Global Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 4:Global Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 5:Global Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 6:Global Safety Lancets Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 7:North America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 8:North America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 9:North America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 10:North America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 11:North America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 12:North America Safety Lancets Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 13:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 14:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 15:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 16:Europe Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 17:Europe Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 18:Europe Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 19:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 20:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 21:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 22:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 23:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 24:Asia Pacific Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 25:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 26:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 27:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 28:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 29:Latin America Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 30:Latin America Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 31:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Type, 2021-2034
- Table 32:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Incision Type, 2021-2034
- Table 33:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
- Table 34:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 35:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, by End-user 2021-2034
- Table 36:Middle East & Africa Safety Lancets Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1:Global Safety Lancets Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2:Global Safety Lancets Market Value Share (%), by Type, 2025 & 2034
- Figure 3:Global Safety Lancets Market Value Share (%), by Incision Type, 2025 & 2034
- Figure 4:Global Safety Lancets Market Value Share (%), by Age Group, 2025 & 2034
- Figure 5:Global Safety Lancets Market Value Share (%), by Application, 2025 & 2034
- Figure 6:Global Safety Lancets Market Value Share (%), by End-user, 2025 & 2034
- Figure 7:Global Safety Lancets Market Value (USD billion), by Region, 2025 & 2034
- Figure 8:North America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
- Figure 9:North America Safety Lancets Market Value Share (%), by Type, 2025
- Figure 10:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 11:North America Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 12:North America Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 13:North America Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 14:North America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
- Figure 15:North America Safety Lancets Market Value Share (%), by Application, 2025
- Figure 16:North America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
- Figure 17:North America Safety Lancets Market Value Share (%), by End-user, 2025
- Figure 18:North America Safety Lancets Market Value (USD billion), By Country, 2025 & 2034
- Figure 19:North America Safety Lancets Market Value Share (%), By Country, 2025
- Figure 20:Europe Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
- Figure 21:Europe Safety Lancets Market Value Share (%), by Type, 2025
- Figure 22:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 23:Europe Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 24:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 25:Europe Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 26:Europe Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
- Figure 27:Europe Safety Lancets Market Value Share (%), by Application, 2025
- Figure 28:Europe Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
- Figure 29:Europe Safety Lancets Market Value Share (%), by End-user, 2025
- Figure 30:Europe Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 31:Europe Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
- Figure 32:Asia Pacific Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
- Figure 33:Asia Pacific Safety Lancets Market Value Share (%), by Type, 2025
- Figure 34:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 35:Asia Pacific Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 36:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 37:Asia Pacific Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 38:Asia Pacific Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
- Figure 39:Asia Pacific Safety Lancets Market Value Share (%), by Application, 2025
- Figure 40:Asia Pacific Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
- Figure 41:Asia Pacific Safety Lancets Market Value Share (%), by End-user, 2025
- Figure 42:Asia Pacific Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 43:Asia Pacific Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
- Figure 44:Latin America Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
- Figure 45:Latin America Safety Lancets Market Value Share (%), by Type, 2025
- Figure 46:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 47:Latin America Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 48:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 49:Latin America Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 50:Latin America Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
- Figure 51:Latin America Safety Lancets Market Value Share (%), by Application, 2025
- Figure 52:Latin America Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
- Figure 53:Latin America Safety Lancets Market Value Share (%), by End-user, 2025
- Figure 54:Latin America Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 55:Latin America Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
- Figure 56:Middle East & Africa Safety Lancets Market Value (USD billion), by Type, 2025 & 2034
- Figure 57:Middle East & Africa Safety Lancets Market Value Share (%), by Type, 2025
- Figure 58:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 59:Middle East & Africa Safety Lancets Market Value Share (%), by Incision Type, 2025
- Figure 60:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 61:Middle East & Africa Safety Lancets Market Value Share (%), by Age Group, 2025
- Figure 62:Middle East & Africa Safety Lancets Market Value (USD billion), by Application, 2025 & 2034
- Figure 63:Middle East & Africa Safety Lancets Market Value Share (%), by Application, 2025
- Figure 64:Middle East & Africa Safety Lancets Market Value (USD billion), by End-user, 2025 & 2034
- Figure 65:Middle East & Africa Safety Lancets Market Value Share (%), by End-user, 2025
- Figure 66:Middle East & Africa Safety Lancets Market Value (USD billion), By Country/Sub-region, 2025 & 2034
- Figure 67:Middle East & Africa Safety Lancets Market Value Share (%), By Country/Sub-region, 2025
- Figure 68:Global Safety Lancets Market Share (%), By Company, 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.